Latest news
Zevra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - tradingview.comtradingview.com · Wed, 05 Aug 2026 22:21:28 GMTZVRA: Strong H1 2026 revenue and cash position support growth in rare disease therapeutics - tradingview.comtradingview.com · Wed, 05 Aug 2026 00:35:00 GMT